为净瘤细胞提供诱和水凝,以增强化疗和缓解转移性传播
Cailian Chen1, Jinying Liu1, Hongbo Zhang2
1Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
Pharmaceutics
|January 8, 2025
概括
一种新型的可注射水凝,称为诱凝 (BH-gel),有效地使用CXCL12招募肺癌细胞,并使用多克索鲁比脂酶消灭它们,显著减少转移和副作用.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 药物运输 药物运输 药物运输
背景情况:
- 肺癌是侵略性的,转移率高,预后不佳.
- 化疗是标准的,但可以促进转移并引起副作用.
研究的目的:
- 开发一种可注射的诱和水凝 (BH-gel) 用于向的肺癌细胞根除.
- 评估BH-凝的抗转移和抗瘤功效在体外和体内.
主要方法:
- 开发了一种可注射的水凝 (BH-凝) 嵌入多克索鲁比脂质体和CXCL12.
- 研究了A549细胞中的瘤细胞招募和抗瘤作用 (体外).
- 在体内评估的抗转移和抗瘤活性.
主要成果:
- 通过持续的CXCL12释放,BH凝成功地招募了瘤细胞.
- 封装的多克索鲁比辛脂质体显示出增强的瘤根除疗效.
- BH凝显著降低了转移和相关心脏毒性和肝毒性.
结论:
- BH-gel采用诱策略来捕捉和杀死肺癌细胞,打击转移.
- 这种方法显示出在抗转移药物中临床应用的巨大潜力.
相关概念视频
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.